CannaPharmaRx Inc
CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Canada. It produces and sells dried cannabis flower. The company is based in Calgary, Canada.
CannaPharmaRx Inc (CPMD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.036x
Based on the latest financial reports, CannaPharmaRx Inc (CPMD) has a cash flow conversion efficiency ratio of 0.036x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-802.70K) by net assets ($-22.52 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CannaPharmaRx Inc - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how CannaPharmaRx Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CannaPharmaRx Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CannaPharmaRx Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lakshmi Finance & Industrial Corporation Limited
NSE:LFIC
|
-0.054x |
|
Pearl Gull Iron Ltd
AU:PLG
|
-0.113x |
|
Lilium N.V.
PINK:LILWF
|
N/A |
|
PT Hetzer Medical Indonesia Tb
JK:MEDS
|
-0.009x |
|
OSI SYSTEMS
MU:OS2
|
-0.047x |
|
AIR PROD.&CHEMICALS
MU:AP3
|
0.076x |
|
Menteng Heritage Realty Tbk PT
JK:HRME
|
-0.006x |
|
Park & Bellheimer AG
F:PKB
|
0.143x |
Annual Cash Flow Conversion Efficiency for CannaPharmaRx Inc (1998–2024)
The table below shows the annual cash flow conversion efficiency of CannaPharmaRx Inc from 1998 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-19.81 Million | $-1.70 Million | 0.086x | -54.22% |
| 2023-12-31 | $-12.15 Million | $-2.27 Million | 0.187x | +124.11% |
| 2022-12-31 | $-17.34 Million | $-1.45 Million | 0.084x | -55.30% |
| 2021-12-31 | $-12.93 Million | $-2.41 Million | 0.187x | +191.75% |
| 2020-12-31 | $-8.80 Million | $-563.57K | 0.064x | +108.19% |
| 2019-12-31 | $4.85 Million | $-3.79 Million | -0.782x | -2804.69% |
| 2018-12-31 | $-774.30K | $-22.38K | 0.029x | -97.04% |
| 2017-12-31 | $-964.30K | $-941.14K | 0.976x | +4076.33% |
| 2016-12-31 | $-957.67K | $-22.38K | 0.023x | -99.37% |
| 2015-12-31 | $-684.54K | $-2.55 Million | 3.723x | -30.36% |
| 2014-12-31 | $-288.23K | $-1.54 Million | 5.347x | +9582.73% |
| 2012-12-31 | $-197.63K | $-10.91K | 0.055x | -54.58% |
| 2011-12-31 | $-99.56K | $-12.10K | 0.122x | -33.43% |
| 2007-12-31 | $-585.00K | $-106.83K | 0.183x | +139.08% |
| 1999-12-31 | $7.17 Million | $-3.35 Million | -0.467x | -9151.05% |
| 1998-12-31 | $1.98 Million | $-10.00K | -0.005x | -- |